Complementary funding
April 5, 2012
THE Complementary Healthcare
Council of Australia is hoping that
the Government’s recent $2.9
million investment into the
Australia New Zealand Clinical Trials
Registry will “perhaps pave the
way” for further investment in
complementary medicine research
and innovation.
“The Complementary Medicines
Industry sees clinical trials as vital
to the sustainability of the Industry,
and reinforcing the significant
impact of complementary
medicines on the health of the
community,” a statement from CHC
ED Dr Wendy Morrow said.
In its 2012 Pre-Budget
Submission, the CHC has called for
a four year Clinical Trials
Partnership, co-funded by the
Industry and Government, which
would enable new and focused
innovation of the preventative
health benefits of key
complementary medicines in the
treatment of specific chronic and
preventative health conditions.
This partnership, according to the
CHC would also help to deal with
intellectual property issues.
“The status quo is stifling
innovation in an industry
motivated by science,” Dr Morrow
said.
“It is preventing research which is
expected to deliver community
access to new non-drug solutions
resulting from the expected high
quality research, which continues
to demonstrate the significant
contribution complementary
medicines can make to improved
community health outcomes,” she
added.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Apr 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Apr 12
